Neonatal Neurologic Intensive Care Network of China
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 28
SponsorChildren's Hospital of Fudan University
About this trial
The purpose of this study is to create a neonatal neurologic biological big data center named Neonatal Neurologic Intensive Care Network in China with neonatal systematic information, biological samples and genomics \& genetic data on neonates born with neonatal severe encephalopathy. It also can predict brain injury as cerebral function monitoring through big data and recommend appropriate treatment. In addition, the following samples will be collected in a bio-bank in for future studies: blood, urine, and cerebrospinal fluid (CSF) samples.
Eligibility criteria
Qualifiers
Postnatal age < or = 28 days
Written informed consent of parent or guardian
Hypoxic ischemic encephalopathy (HIE)
Hydrocephalus
Disqualifiers
Known other major congenital anomalies but not not neurologic disease.
Failed to get sample or the volume of collected biosamples is not enough.
Parents refuse consent.
Trial design
Treatments tested in this trial
- Database Entry/Biospecimen Collection
Treatment groups
2,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Children's Hospital of Fudan University
Lead sponsor
Xiamen Children's Hospital, Fujian of China
Collaborator
Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Collaborator
Guangzhou Women and Children's Medical Center
Collaborator
Yuying Children's Hospital of Wenzhou Medical University
Collaborator
Maternal and Child Health Hospital of Hubei Province
Collaborator
The People's Hospital of Dehong Autonomous Prefecture
Collaborator
Guangzhou Medical University
Collaborator
Nanfang Hospital, Southern Medical University
Collaborator
Source ClinicalTrials.gov